Docetaxel: all 1,319 studies that test it
Page 10 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerStatus unknownNCT00625937Phase 2
- Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerCompletedNCT00622349Phase 3
- To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single AgentTerminatedNCT00620100Phase 2
- Study of Sorafenib and Docetaxel in Metastatic Prostate CancerCompletedNCT00619996Phase 2
- GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerCompletedNCT00617968Phase 2
- Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast CancerCompletedNCT00615602Phase 3
- Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the UterusCompletedNCT00614835Not applicable
- Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00606814Phase 1
- Neoadjuvant Endostatin and Chemotherapy for Breast CancerCompletedNCT00604435Phase 2
- Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.CompletedNCT00600249Phase 2
- Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the ProstateWithdrawnNCT00598858Phase 2
- The Synergism Or Long Duration (SOLD) StudyCompletedNCT00593697Phase 3
- Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric CancerStatus unknownNCT00587145Phase 2
- Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung CancerCompletedNCT00582634Phase 2
- Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate CancerTerminatedNCT00582582Phase 2
- Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerCompletedNCT00574769Phase 1/2
- A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00571675Phase 2
- Study of Weekly DCF to Treat Advanced Gastric CancerTerminatedNCT00568971Phase 2
- Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.TerminatedNCT00565227Phase 1
- Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate CancerCompletedNCT00559429Phase 1
- Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck CancerTerminatedNCT00557206Phase 2
- Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone TherapyCompletedNCT00554918Phase 2
- A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer PatientsCompletedNCT00545246Phase 1
- A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung CancerCompletedNCT00544960Phase 2
- German Preoperative Adriamycin Docetaxel StudyCompletedNCT00543829Phase 2
- BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast CancerCompletedNCT00540800Phase 3
- A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)TerminatedNCT00539968Phase 1/2
- TAX + Carboplatin or Cisplatin 1st Line Post-Surgery OvarianCompletedNCT00539669Phase 2
- TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHNCompletedNCT00539630Phase 3
- Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast CancerCompletedNCT00538525Not applicable
- A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric CancerCompletedNCT00533533Phase 1/2
- ABI-008 Trial in Patients With Metastatic Breast CancerTerminatedNCT00531271Phase 1/2
- Taxotere/Temodar/Cisplatin Study in Melanoma PatientsCompletedNCT00527761Phase 1
- Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/DocetaxelCompletedNCT00527449Phase 2
- Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast CancerCompletedNCT00525759Phase 2
- p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal CancerCompletedNCT00525200Phase 3
- Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric CancerCompletedNCT00525005Phase 2
- Liposomal Doxorubicin and Docetaxel in Metastatic Breast CancerCompletedNCT00524810Phase 2
- Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck CancerCompletedNCT00521521Phase 2
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNCT00511576Phase 1
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric CancerCompletedNCT00511446Phase 2
- Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical TrialCompletedNCT00502463Not applicable
- Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate CancerTerminatedNCT00494338Phase 2
- Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate CancerCompletedNCT00482807Phase 1
- ABI-008 Trial in Patients With Hormone-refractory Prostate CancerCompletedNCT00477529Phase 1/2
- A Phase I Study of Intraperitoneal Hyperthermic DocetaxelCompletedNCT00474669Phase 1
- OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
- A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.WithdrawnNCT00471159Phase 2
- Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerTerminatedNCT00461344Phase 2
- PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid TumorsCompletedNCT00459836Phase 1
- Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsTerminatedNCT00453635Phase 2
- Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical CancerWithdrawnNCT00452920Phase 1/2
- The ELDORADO (Eligard®, Docetaxel and Radiotherapy) StudyStatus unknownNCT00452556Phase 2
- Phase I/II Study of Neoadjuvant Lapatinib in Breast CancerCompletedNCT00450892Phase 1/2
- Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate CancerTerminatedNCT00450008Phase 2
- Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerCompletedNCT00449020Phase 2
- Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before ProstatectomyTerminatedNCT00448097Phase 2
- Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00445861Phase 1/2
- Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLCTerminatedNCT00442026Phase 3
- Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00441922Phase 3
- Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung CancerCompletedNCT00441740Phase 3
- The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With CancerCompletedNCT00440128Phase 1
- Taxotere Prostate Cancer New Indication Registration Trial in ChinaCompletedNCT00436839Phase 3
- Taxotere + Cisplatin in Nasopharyngeal CarcinomaCompletedNCT00436293Phase 2
- CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWithdrawnNCT00434031Phase 2
- Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 3
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00432315Phase 2
- Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast CancerCompletedNCT00431080Phase 3
- Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian CancerCompletedNCT00431054Phase 1
- Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast CancerStatus unknownNCT00430001Phase 3
- Breast Cancer Treated by Neoadjuvant ChemotherapyCompletedNCT00425516Phase 2
- Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer PatientsCompletedNCT00424606Phase 3
- Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00416533Phase 2
- ZANTE: Zometa and Taxotere in Hormone Refractory Prostate CancerCompletedNCT00415779Phase 1
- Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast CancerStatus unknownNCT00415285Phase 2
- Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415116Phase 1
- Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)CompletedNCT00406302Phase 2
- Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung CancerCompletedNCT00405951Phase 1/2
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic CancerCompletedNCT00405210Phase 1
- C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00402545Phase 1
- A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate CancerCompletedNCT00401765Phase 1
- Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT00401323Phase 2/3
- Docetaxel and Temozolomide in Treating Patients With Metastatic CancerCompletedNCT00401180Phase 1
- Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00398489Phase 2
- A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.WithdrawnNCT00386555Phase 2
- Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast CancerCompletedNCT00379015Phase 2
- Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLCTerminatedNCT00378404Phase 1
- Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate CancerStatus unknownNCT00376792Phase 3
- Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal JunctionCompletedNCT00374985Phase 1/2
- AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid TumorsCompletedNCT00372736Phase 1
- Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GISTCompletedNCT00359333Phase 2
- AEG35156 and Docetaxel in Treating Patients With Solid TumorsCompletedNCT00357747Phase 1
- Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLCTerminatedNCT00356941Phase 1
- Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast CancerCompletedNCT00352378Phase 3
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2
- ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant TreatmentCompletedNCT00331097Phase 3
- Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsCompletedNCT00327288Phase 1
- Trial With Taxotere and Cisplatin in Non-operable Adrenocortical CarcinomaCompletedNCT00324012Phase 2
- Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast CancerCompletedNCT00322400Phase 1